No kidney disease | Mild kidney disease | Moderate kidney disease | Total cohort | p value | |
---|---|---|---|---|---|
Age (years); Median (IQR) | 30 (22–40)a | 30 (19.75-54.25)b | 52.5 (46–64.75)a,b,c | 31 (22–43) | 0.000** |
n | 292 | 30 | 28 | 350 | |
BMI (kg/m2); Median (IQR) | 21 (18.6-25.3)a | 21.8 (18.5-27.4)b | 23.9 (20.4-28.6)c | 21.33 (18.64-25.5) | 0.09 |
n | 290 | 30 | 28 | 348 | |
SBP (mmHg); Median (IQR) | 118.7 (110.3-128.0)a | 123.7 (109.6-130.0)b | 133.0 (122.3-158.0)a,b,c | 119.67 (110.67-129.67) | 0.000** |
n | 291 | 30 | 28 | 349 | |
DBP (mmHg); Median (IQR) | 75.0 (69.0-82.3)a | 77.5 (70.5-82.7)b | 83.7 (73.9-96.4)a,c | 75.7 (69.3-83.0) | 0.004* |
n | 291 | 30 | 28 | 349 | |
Creatinine (mg/dl); Median (IQR) | 0.9 (0.8-1)a | 0.9 (0.8-1.1)a,b | 1.3 (1.12-1.48)a,c | 0.9 (0.8-1.1) | 0.000** |
n | 292 | 30 | 28 | 350 | |
BSR (mg/dl); Median (IQR) | 95 (87–106.25)a | 98.5 (85.7-117.75)a,b | 104.5 (91.5-141)a,c | 96 (87–111) | 0.03* |
n | 290 | 30 | 28 | 348 | |
HBA1C (%); Median (IQR) | 5.3 (4.8-5.8)a | 5.8 (4.9-6.02)a,b | 5.65 (4.82-6.07)a,c | 5.4 (4.8-5.8) | 0.03* |
n | 288 | 30 | 28 | 346 | |
Total CL (mg/dl); Median (IQR) | 155.5 (138–184)a | 148.5 (128–177.25)b | 164 (138.5-220.75)c | 155 (137–184) | 0.3 |
n | 292 | 30 | 28 | 350 | |
HDL (mg/dl); Median (IQR) | 40 (35–45)a | 37.5 (31.75-42)a,b | 42 (37–45)a,c | 40 (34–45) | 0.03* |
n | 292 | 30 | 27 | 349 |